CVS Health Corp
XETRA:CVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CVS Health Corp
XETRA:CVS
|
US |
|
Dovalue SpA
MIL:DOV
|
IT |
|
Crossfirst Bankshares Inc
NASDAQ:CFB
|
US |
|
Futaba Industrial Co Ltd
TSE:7241
|
JP |
|
Dream Industrial Real Estate Investment Trust
TSX:DIR.UN
|
CA |
|
C
|
Complete Solaria Inc
NASDAQ:CSLR
|
US |
|
Walker Crips Group PLC
LSE:WCW
|
UK |
|
C
|
CeriBell Inc
NASDAQ:CBLL
|
US |
|
DIRTT Environmental Solutions Ltd
TSX:DRT
|
CA |
|
Allegro Microsystems Inc
NASDAQ:ALGM
|
US |
|
Precise Biometrics AB
STO:PREC
|
SE |
|
Dada Nexus Ltd
NASDAQ:DADA
|
CN |
Wall Street
Price Targets
CVS Price Targets Summary
CVS Health Corp
According to Wall Street analysts, the average 1-year price target for
CVS
is 81.34 EUR
with a low forecast of 67.79 EUR and a high forecast of 93.67 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CVS's stock price target?
Price Target
81.34
EUR
According to Wall Street analysts, the average 1-year price target for
CVS
is 81.34 EUR
with a low forecast of 67.79 EUR and a high forecast of 93.67 EUR.
What is CVS Health Corp's Revenue forecast?
Projected CAGR
4%
For the last 14 years the
compound annual growth rate for
CVS Health Corp's revenue is
10%.
The projected
CAGR
for the next 3 years is
4%.
What is CVS Health Corp's Operating Income forecast?
Projected CAGR
22%
For the last 14 years the
compound annual growth rate for
CVS Health Corp's operating income is
4%.
The projected
CAGR
for the next 3 years is
22%.
What is CVS Health Corp's Net Income forecast?
Projected CAGR
90%
For the last 14 years the
compound annual growth rate for
CVS Health Corp's net income is
-5%.
The projected
CAGR
for the next 3 years is
90%.
